Study of Abarelix in Androgen-Independent Prostate Cancer Progressing After Agonist Therapy

NCT00100243 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
22
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

PRAECIS Pharmaceuticals Inc.